Adiponectin: Role in Physiology and Pathophysiology

Thi Mong Diep Nguyen


Adiponectin, an adipokine secreted by adipocytes, is a well‑known homeostatic factor for regulating glucose levels, lipid metabolism, and insulin sensitivity through its anti‑inflammatory, anti‑fibrotic, and antioxidant effects. All these metabolic processes are mediated via two adiponectin receptors, AdipoR1 and AdipoR2. In addition, adiponectin is one of the hormones with the highest plasma concentrations. Weight loss or caloric restriction leads to increasing adiponectin levels, and this increase is associated with increased insulin sensitivity. Therefore, the adiponectin pathway can play a crucial role in the development of drugs to treat type 2 diabetes mellitus and other obesity‑related diseases affected by insulin resistance like cancers or cardiovascular diseases. Adiponectin appears to increase insulin sensitivity by improving glucose and lipid metabolisms. The objective of this review is to analyze current knowledge concerning adiponectin and, in particular, its role in physiology and pathophysiology.


Adipokines; adiponectin; AdipoR; obesity; type 2 diabetes mellitus

Full Text:



Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF.

A novel serum protein similar to C1q, produced exclusively in

adipocytes. J Biol Chem 1995;270:26746‑9.

Hu E, Liang P, Spiegelman BM. AdipoQ is a novel

adipose‑specific gene dysregulated in obesity. J Biol Chem


Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y,

Matsubara K. cDNA cloning and expression of a novel adipose

specific collagen‑like factor, apM1 (AdiPose Most abundant Gene

transcript 1). Biochem Biophys Res Commun 1996;221:286‑9.

Nakano Y, Tobe T, Choi‑Miura NH, Mazda T, Tomita M. Isolation

and characterization of GBP28, a novel gelatin‑binding protein

purified from human plasma. J Biochem 1996;120:803‑12.

Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM.

Induction of adiponectin in skeletal muscle by inflammatory

cytokines: In vivo and in vitro studies. Endocrinology


Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J,

et al. Adiponectin is synthesized and secreted by human and

murine cardiomyocytes. FEBS Lett 2005;579:5163‑9.

Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L,

Drevon CA, et al. Adiponectin and its receptors are expressed in

bone‑forming cells. Bone 2004;35:842‑9.

Crawford LJ, Peake R, Price S, Morris TC, Irvine AE.

Adiponectin is produced by lymphocytes and is a negative

regulator of granulopoiesis. J Leukoc Biol 2010;88:807‑11.

Paschke L, Zemleduch T, Rucinski M, Ziolkowska A, Szyszka M,

Malendowicz LK. Adiponectin and adiponectin receptor system

in the rat adrenal gland: Ontogenetic and physiologic regulation,

and its involvement in regulating adrenocortical growth and

steroidogenesis. Peptides 2010;31:1715‑24.

Caminos JE, Nogueiras R, Gallego R, Bravo S, Tovar S,

Garcia‑Caballero T, et al. Expression and regulation of

adiponectin and receptor in human and rat placenta. J Clin

Endocrinol Metab 2005;90:4276‑86.

Caminos JE, Nogueiras R, Gaytan F, Pineda R, Gonzalez CR,

Barreiro ML, et al. Novel expression and direct effects of

adiponectin in the rat testis. Endocrinology 2008;149:3390‑402.

Chabrolle C, Tosca L, Dupont J. Regulation of adiponectin and

its receptors in rat ovary by human chorionic gonadotrophin

treatment and potential involvement of adiponectin in granulosa

cell steroidogenesis. Reproduction 2007;133:719‑31.

Rodriguez‑Pacheco F, Martinez‑Fuentes AJ, Tovar S, Pinilla L,

Tena‑Sempere M, Dieguez C, et al. Regulation of pituitary cell

function by adiponectin. Endocrinology 2007;148:401‑10.

Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY. Expression of

adiponectin and its receptors in livers of morbidly obese patients

with non‑alcoholic fatty liver disease. J Gastroenterol Hepatol


Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of

Acrp30/adiponectin structural and functional paralogs. Proc Natl

Acad Sci U S A 2004;101:10302‑7.

Fruebis J, Tsao TS, Javorschi S, Ebbets‑Reed D, Erickson MR,

Yen FT, et al. Proteolytic cleavage product of 30‑kDa adipocyte

complement‑related protein increases fatty acid oxidation in

muscle and causes weight loss in mice. Proc Natl Acad Sci U S

A 2001;98:2005‑10.

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K,

Miyagawa J, et al. Paradoxical decrease of an adipose‑specific protein, adiponectin, in obesity. Biochem Biophys Res Commun


Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O,

Ebinuma H, et al. Measurement of the high‑molecular weight

form of adiponectin in plasma is useful for the prediction of

insulin resistance and metabolic syndrome. Diabetes Care


Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y,

et al. Selective suppression of endothelial cell apoptosis by

the high molecular weight form of adiponectin. Circ Res


Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T,

Berger JP, et al. Complex distribution, not absolute amount

of adiponectin, correlates with thiazolidinedione‑mediated

improvement in insulin sensitivity. J Biol Chem


Wang Y, Lam KS, Yau MH, Xu A. Post‑translational

modifications of adiponectin: Mechanisms and functional

implications. Biochem J 2008;409:623‑33.

Andersen KK, Frystyk J, Wolthers OD, Heuck C, Flyvbjerg A.

Gender differences of oligomers and total adiponectin during

puberty: A cross‑sectional study of 859 Danish school children.

J Clin Endocrinol Metab 2007;92:1857‑62.

Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A,

Devlin AM. Total and high molecular weight adiponectin and

ethnic‑specific differences in adiposity and insulin resistance:

A cross‑sectional study. Cardiovasc Diabetol 2013;12:170.

Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK,

Boyko EJ, et al. Relationship of adiponectin to body fat

distribution, insulin sensitivity and plasma lipoproteins:

Evidence for independent roles of age and sex. Diabetologia


Arai Y, Nakazawa S, Kojima T, Takayama M, Ebihara Y,

Shimizu KI, et al. High adiponectin concentration and its role

for longevity in female centenarians. Geriatr Gerontol Int


Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL,

Mantzoros CS. Diurnal and ultradian dynamics of serum

adiponectin in healthy men: Comparison with leptin, circulating

soluble leptin receptor, and cortisol patterns. J Clin Endocrinol

Metab 2003;88:2838‑43.

Swarbrick MM, Havel PJ. Physiological, pharmacological, and

nutritional regulation of circulating adiponectin concentrations in

humans. Metab Syndr Relat Disord 2008;6:87‑102.

Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S,

et al. Cloning of adiponectin receptors that mediate antidiabetic

metabolic effects. Nature 2003;423:762‑9.

Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF.

T‑cadherin is a receptor for hexameric and high‑molecular‑weight

forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A


Yamauchi T, Iwabu M, Okada‑Iwabu M, Kadowaki T.

Adiponectin receptors: A review of their structure, function

and how they work. Best Pract Res Clin Endocrinol Metab


Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of

adiponectin receptors in pancreatic beta cells. Biochem Biophys

Res Commun 2003;312:1118‑22.

Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T,

Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2

causes abrogation of adiponectin binding and metabolic actions.

Nat Med 2007;13:332‑9.

Bjursell M, Ahnmark A, Bohlooly YM, William‑Olsson L,

Rhedin M, Peng XR, et al. Opposing effects of adiponectin

receptors 1 and 2 on energy metabolism. Diabetes


Matsuda K, Fujishima Y, Maeda N, Mori T, Hirata A,

Sekimoto R, et al. Positive feedback regulation between

adiponectin and T‑cadherin impacts adiponectin levels in tissue

and plasma of male mice. Endocrinology 2015;156:934‑46.

Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S,

et al. The unique prodomain of T‑cadherin plays a key role in

adiponectin binding with the essential extracellular cadherin

repeats 1 and 2. J Biol Chem 2017;292:7840‑9.

Obata Y, Kita S, Koyama Y, Fukuda S, Takeda H, Takahashi M,

et al. Adiponectin/T‑cadherin system enhances exosome

biogenesis and decreases cellular ceramides by exosomal release.

JCI Insight 2018;3:e99680.

Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T,

Maeda N, Miranda LM, et al. Adiponectin downregulates

its own production and the expression of its AdipoR2

receptor in transgenic mice. Biochem Biophys Res Commun


Kim MJ, Maachi M, Debard C, Loizon E, Clement K,

Bruckert E, et al. Increased adiponectin receptor‑1 expression in

adipose tissue of impaired glucose‑tolerant obese subjects during

weight loss. Eur J Endocrinol 2006;155:161‑5.

Bluher M. Adipose tissue inflammation: A cause or consequence

of obesity‑related insulin resistance? Clin Sci (Lond)


Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM,

Rasmussen M, Richelsen B. Adiponectin receptors in human

adipose tissue: Effects of obesity, weight loss, and fat depots.

Obesity (Silver Spring) 2006;14:28‑35.

McAinch AJ, Steinberg GR, Mollica J, O’Brien PE, Dixon JB,

Macaulay SL, et al. Differential regulation of adiponectin

receptor gene expression by adiponectin and leptin in myotubes

derived from obese and diabetic individuals. Obesity (Silver

Spring) 2006;14:1898‑904.

Storgaard H, Poulsen P, Ling C, Groop L, Vaag AA.

Relationships of plasma adiponectin level and adiponectin

receptors 1 and 2 gene expression to insulin sensitivity and

glucose and fat metabolism in monozygotic and dizygotic twins.

J Clin Endocrinol Metab 2007;92:2835‑9.

Ordelheide AM, Heni M, Gommer N, Gasse L, Haas C,

Guirguis A, et al. The myocyte expression of adiponectin

receptors and PPARδ is highly coordinated and reflects

lipid metabolism of the human donors. Exp Diabetes Res


Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H,

et al. Recent advances in the relationship between obesity,

inflammation, and insulin resistance. Eur Cytokine Netw


Antuna‑Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: The

missing link between insulin resistance and obesity. Diabetes

Metab 2008;34:2‑11.

Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK,

Trumbauer ME, et al. Mice lacking adiponectin show decreased

hepatic insulin sensitivity and reduced responsiveness to

peroxisome proliferator‑activated receptor gamma agonists.

J Biol Chem 2006;281:2654‑60.

Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB,

Gorden P, et al. Plasma adiponectin as a marker of insulin

receptor dysfunction: Clinical utility in severe insulin resistance.

Diabetes Care 2008;31:977‑9.

Okamoto M, Ohara‑Imaizumi M, Kubota N, Hashimoto S, Eto K, Kanno T, et al. Adiponectin induces insulin secretion

in vitro and in vivo at a low glucose concentration. Diabetologia


Wijesekara N, Krishnamurthy M, Bhattacharjee A, Suhail A,

Sweeney G, Wheeler MB. Adiponectin‑induced ERK and Akt

phosphorylation protects against pancreatic beta cell apoptosis

and increases insulin gene expression and secretion. J Biol Chem


Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S,

et al. Adiponectin stimulates glucose utilization and fatty‑acid

oxidation by activating AMP‑activated protein kinase. Nat Med


Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G,

Sweeney G. Globular adiponectin increases GLUT4 translocation

and glucose uptake but reduces glycogen synthesis in rat skeletal

muscle cells. Diabetologia 2005;48:132‑9.

Mao X, Kikani CK, Riojas RA, Langlais P, Wang L,

Ramos FJ, et al. APPL1 binds to adiponectin receptors and

mediates adiponectin signalling and function. Nat Cell Biol


Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L.

Endogenous glucose production is inhibited by the

adipose‑derived protein Acrp30. J Clin Invest 2001;108:1875‑81.

Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes

adipocyte differentiation, insulin sensitivity, and lipid

accumulation. J Lipid Res 2005;46:1369‑79.

Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular

risk. Int J Cardiol 2013;169:166‑76.

Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI,

et al. Enhanced muscle fat oxidation and glucose transport by

ACRP30 globular domain: Acetyl‑CoA carboxylase inhibition

and AMP‑activated protein kinase activation. Proc Natl Acad Sci

U S A 2002;99:16309‑13.

Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB.

Adiponectin increases fatty acid oxidation in skeletal muscle

cells by sequential activation of AMP‑activated protein

kinase, p38 mitogen‑activated protein kinase, and peroxisome

proliferator‑activated receptor alpha. Diabetes 2006;55:2562‑70.

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K,

et al. The fat‑derived hormone adiponectin reverses insulin

resistance associated with both lipoatrophy and obesity. Nat Med


Liu Q, Yuan B, Lo KA, Patterson HC, Sun Y, Lodish HF.

Adiponectin regulates expression of hepatic genes critical

for glucose and lipid metabolism. Proc Natl Acad Sci U S A


Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y,

Ohashi K, et al. Adiponectin specifically increased tissue

inhibitor of metalloproteinase‑1 through interleukin‑10

expression in human macrophages. Circulation 2004;109:2046‑9.

Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H,

et al. Adiponectin, an adipocyte‑derived plasma protein, inhibits

endothelial NF‑kappaB signaling through a cAMP‑dependent

pathway. Circulation 2000;102:1296‑301.

Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P,

Jimenez‑Chillaron JC. Sexual differentiation, pregnancy, calorie

restriction, and aging affect the adipocyte‑specific secretory

protein adiponectin. Diabetes 2003;52:268‑76.

Gui Y, Silha JV, Murphy LJ. Sexual dimorphism and regulation

of resistin, adiponectin, and leptin expression in the mouse. Obes

Res 2004;12:1481‑91.

Yu H, Chhabra KH, Thompson Z, Jones GL, Kiran S,

Shangguan G, et al. Hypothalamic POMC deficiency

increases circulating adiponectin despite obesity. Mol Metab


Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H,

Nagaretani H, et al. Androgens decrease plasma adiponectin,

an insulin‑sensitizing adipocyte‑derived protein. Diabetes


Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M,

Matsui J, et al. Disruption of adiponectin causes insulin resistance

and neointimal formation. J Biol Chem 2002;277:25863‑6.

Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M,

Maeda N, et al. Role of adiponectin in preventing vascular

stenosis. The missing link of adipo‑vascular axis. J Biol Chem


Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M,

et al. Adiponectin reduces atherosclerosis in apolipoprotein

E‑deficient mice. Circulation 2002;106:2767‑70.

Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T,

Ujiie H, et al. Adiponectin acts as an endogenous antithrombotic

factor. Arterioscler Thromb Vasc Biol 2006;26:224‑30.

Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S,

Ohashi K, et al. Adiponectin protects against myocardial

ischemia‑reperfusion injury through AMPK‑ and

COX‑2‑dependent mechanisms. Nat Med 2005;11:1096‑103.

Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al.

Genetic variation in the gene encoding adiponectin is associated

with an increased risk of type 2 diabetes in the Japanese

population. Diabetes 2002;51:536‑40.

Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM,

Ramachandran A. Plasma adiponectin is an independent

predictor of type 2 diabetes in Asian indians. Diabetes Care


Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T.

Adiponectin, an adipocyte‑derived protein, predicts future insulin

resistance: Two‑year follow‑up study in Japanese population.

J Clin Endocrinol Metab 2004;89:87‑90.

Zhou L, Liu M, Zhang J, Chen H, Dong LQ, Liu F. DsbA‑L

alleviates endoplasmic reticulum stress‑induced adiponectin

downregulation. Diabetes 2010;59:2809‑16.

Soares AF, Guichardant M, Cozzone D, Bernoud‑Hubac N,

Bouzaidi‑Tiali N, Lagarde M, et al. Effects of oxidative stress

on adiponectin secretion and lactate production in 3T3‑L1

adipocytes. Free Radic Biol Med 2005;38:882‑9.

Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y,

Tanaka S, Tataranni PA, et al. Adiponectin and development

of type 2 diabetes in the Pima Indian population. Lancet


Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M,

Matsuda M, et al. Association of adiponectin mutation with

type 2 diabetes: A candidate gene for the insulin resistance

syndrome. Diabetes 2002;51:2325‑8.

Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M,

Boeing H, et al. Adiponectin and protection against type 2

diabetes mellitus. Lancet 2003;361:226‑8.

Vansaun MN. Molecular pathways: Adiponectin and leptin

signaling in cancer. Clin Cancer Res 2013;19:1926‑32.

Schott S, Schneeweiss A, Sohn C. Breast cancer and diabetes

mellitus. Exp Clin Endocrinol Diabetes 2010;118:673‑7.

Rzepka‑Gorska I, Bedner R, Cymbaluk‑Ploska A,

Chudecka‑Glaz A. Serum adiponectin in relation to endometrial

cancer and endometrial hyperplasia with atypia in obese women.

Eur J Gynaecol Oncol 2008;29:594‑7.

Jin JH, Kim HJ, Kim CY, Kim YH, Ju W, Kim SC.

Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer. Obstet

Gynecol Sci 2016;59:279‑85.

Tiwari A, Ocon‑Grove OM, Hadley JA, Giles JR, Johnson PA,

Ramachandran R. Expression of adiponectin and its receptors is

altered in epithelial ovarian tumors and ascites‑derived ovarian

cancer cell lines. Int J Gynecol Cancer 2015;25:399‑406.

Li X, Yu Z, Fang L, Liu F, Jiang K. Expression of adiponectin

receptor‑1 and prognosis of epithelial ovarian cancer patients.

Med Sci Monit 2017;23:1514‑21.

Hoffmann M, Gogola J, Ptak A. Adiponectin reverses the

proliferative effects of estradiol and IGF‑1 in human epithelial

ovarian cancer cells by downregulating the expression of their

receptors. Horm Cancer 2018;9:166‑74.

Mitsiades N, Pazaitou‑Panayiotou K, Aronis KN, Moon HS,

Chamberland JP, Liu X, et al. Circulating adiponectin is

inversely associated with risk of thyroid cancer: In vivo and

in vitro studies. J Clin Endocrinol Metab 2011;96:E2023‑8.

Hu MB, Xu H, Hu JM, Zhu WH, Yang T, Jiang HW, et al.

Genetic polymorphisms in leptin, adiponectin and their

receptors affect risk and aggressiveness of prostate cancer:

Evidence from a meta‑analysis and pooled‑review. Oncotarget


Michalakis K, Williams CJ, Mitsiades N, Blakeman J,

Balafouta‑Tselenis S, Giannopoulos A, et al. Serum adiponectin

concentrations and tissue expression of adiponectin receptors are

reduced in patients with prostate cancer: A case control study.

Cancer Epidemiol Biomarkers Prev 2007;16:308‑13.

Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA,

et al. Tumor expression of adiponectin receptor 2 and lethal

prostate cancer. Carcinogenesis 2015;36:639‑47.

Jiang J, Fan Y, Zhang W, Shen Y, Liu T, Yao M, et al.

Adiponectin suppresses human pancreatic cancer growth through

attenuating the beta‑catenin signaling pathway. Int J Biol Sci


Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al.

Adiponectin represses colon cancer cell proliferation via

AdipoR1‑ and ‑R2‑mediated AMPK activation. Mol Endocrinol